4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-010079
CHIEF COMMERCIAL OFFICER gave up 880 shares (to pay taxes)
- CHIEF COMMERCIAL OFFICER acquired 1,612 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-01 | Option exercise | +1,612 | 16,032 | D | ||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-01 | Shares withheld for taxes | −880 | $19.70 | $17,336 | 15,152 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2024-04-01 | Option exercise · Restricted Share Unit | −1,612 | 4,833 | D | ||
Loading xslF345X05/form4-04032024_090405.xml…